Back to Search Start Over

Acute liver failure secondary to ABVD use.

Acute liver failure secondary to ABVD use.

Authors :
Eslami A
Mathur AD
Jha KK
Wang H
Source :
BMJ case reports [BMJ Case Rep] 2018 Jul 30; Vol. 2018. Date of Electronic Publication: 2018 Jul 30.
Publication Year :
2018

Abstract

Hodgkin's lymphoma (HL) is a type of cancer originating in the lymph nodes. The preferred therapy for advanced HL is a combination of chemotherapies including doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD). ABVD has been standard therapy for advanced HL. It is generally considered as safe and rarely has been reported to cause acute liver failure. We present a case of 79-year-old woman with HL, who developed acute liver failure secondary to first cycle of ABVD chemotherapy.<br />Competing Interests: Competing interests: None declared.<br /> (© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1757-790X
Volume :
2018
Database :
MEDLINE
Journal :
BMJ case reports
Publication Type :
Academic Journal
Accession number :
30061135
Full Text :
https://doi.org/10.1136/bcr-2018-225474